DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

Detalles Bibliográficos
Autores principales: Zhu, Zhongling, Chen, Peng, Yan, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068455/
https://www.ncbi.nlm.nih.gov/pubmed/29932513
http://dx.doi.org/10.1111/1759-7714.12785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068455/
https://www.ncbi.nlm.nih.gov/pubmed/29932513
http://dx.doi.org/10.1111/1759-7714.12785

Ejemplares similares